| renal tubular secretion | GO:0097254 | 2 | 0.839 | |
| cellular response to peptide | GO:1901653 | 92 | 0.824 | |
| response to osmotic stress | GO:0006970 | 21 | 0.751 | |
| hexose transmembrane transport | GO:0035428 | 7 | 0.673 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.657 | |
| vitamin transport | GO:0051180 | 10 | 0.630 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.614 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.614 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.597 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.571 | |
| response to fructose | GO:0009750 | 2 | 0.516 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.461 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.441 | |
| response to peptide hormone | GO:0043434 | 127 | 0.432 | |
| renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure | GO:0003072 | 5 | 0.432 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.423 | |
| secondary metabolite catabolic process | GO:0090487 | 1 | 0.375 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.358 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.339 | |
| angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 3 | 0.336 | |
| response to peptide | GO:1901652 | 136 | 0.332 | |
| naphthalene metabolic process | GO:0018931 | 1 | 0.322 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.310 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.307 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.292 | |
| response to insulin | GO:0032868 | 100 | 0.285 | |
| naphthalene containing compound metabolic process | GO:0090420 | 1 | 0.282 | |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.275 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.274 | |
| regulation of serine type endopeptidase activity | GO:1900003 | 2 | 0.261 | |
| carnitine transmembrane transport | GO:1902603 | 3 | 0.259 | |
| amine metabolic process | GO:0009308 | 45 | 0.253 | |
| transmembrane transport | GO:0055085 | 412 | 0.250 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.243 | Mouse |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.243 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.243 | |
| cellular response to starvation | GO:0009267 | 57 | 0.224 | Human |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.221 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.221 | |
| cellular alcohol metabolic process | GO:0044107 | 3 | 0.220 | |
| cellular response to fructose stimulus | GO:0071332 | 2 | 0.214 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.213 | |
| toxin catabolic process | GO:0009407 | 1 | 0.213 | |
| response to chromate | GO:0046687 | 1 | 0.206 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.204 | |
| dehydroascorbic acid transport | GO:0070837 | 3 | 0.201 | |
| response to metal ion | GO:0010038 | 47 | 0.198 | |
| negative regulation of serine type endopeptidase activity | GO:1900004 | 2 | 0.193 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.182 | |
| negative regulation of fibrinolysis | GO:0051918 | 1 | 0.181 | |
| hormone metabolic process | GO:0042445 | 86 | 0.180 | Mouse |
| positive regulation of protein kinase c activity | GO:1900020 | 1 | 0.178 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.172 | |
| fat cell differentiation | GO:0045444 | 160 | 0.171 | |
| oxidation reduction process | GO:0055114 | 342 | 0.171 | |
| inflammatory response | GO:0006954 | 244 | 0.167 | |
| negative regulation of complement activation | GO:0045916 | 3 | 0.167 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.166 | Mouse |
| protein maturation | GO:0051604 | 176 | 0.162 | |
| anion transport | GO:0006820 | 177 | 0.162 | |
| protein processing | GO:0016485 | 163 | 0.158 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.157 | Mouse |
| regulation of estrogen secretion | GO:2000861 | 1 | 0.157 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.154 | |
| unsaturated fatty acid metabolic process | GO:0033559 | 31 | 0.153 | |
| medium chain fatty acid metabolic process | GO:0051791 | 1 | 0.152 | |
| oxidative demethylation | GO:0070989 | 1 | 0.150 | |
| response to nutrient levels | GO:0031667 | 109 | 0.150 | Human |
| organic anion transport | GO:0015711 | 137 | 0.150 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.150 | |
| renal system process | GO:0003014 | 48 | 0.146 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.144 | |
| fibrinolysis | GO:0042730 | 3 | 0.144 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.141 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.136 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.131 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.127 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.126 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.123 | Mouse |
| steroid metabolic process | GO:0008202 | 119 | 0.123 | Mouse |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.120 | |
| positive regulation of fatty acid biosynthetic process | GO:0045723 | 3 | 0.118 | |
| lipid catabolic process | GO:0016042 | 69 | 0.117 | |
| cell adhesion | GO:0007155 | 329 | 0.117 | |
| regulation of protein processing | GO:0070613 | 96 | 0.117 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.116 | Mouse |
| icosanoid metabolic process | GO:0006690 | 33 | 0.115 | |
| regulation of blood vessel size by renin angiotensin | GO:0002034 | 5 | 0.115 | |
| retinol metabolic process | GO:0042572 | 9 | 0.112 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.111 | |
| response to inorganic substance | GO:0010035 | 96 | 0.110 | |
| ovarian follicle rupture | GO:0001543 | 2 | 0.109 | |
| amylopectin biosynthetic process | GO:0010021 | 1 | 0.109 | |
| amino acid betaine transport | GO:0015838 | 3 | 0.108 | |
| regulation of secretion | GO:0051046 | 274 | 0.106 | |
| response to starvation | GO:0042594 | 65 | 0.106 | Human |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.106 | |
| fat soluble vitamin metabolic process | GO:0006775 | 11 | 0.105 | Mouse |
| regulation of renal output by angiotensin | GO:0002019 | 2 | 0.105 | |
| progesterone metabolic process | GO:0042448 | 4 | 0.104 | Mouse |
| sterol metabolic process | GO:0016125 | 58 | 0.102 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.099 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.099 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.099 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.099 | |
| spermatogenesis | GO:0007283 | 284 | 0.098 | |
| positive regulation of activation of membrane attack complex | GO:0001970 | 2 | 0.098 | |
| response to transition metal nanoparticle | GO:1990267 | 11 | 0.097 | |
| male gamete generation | GO:0048232 | 285 | 0.096 | |
| complement activation | GO:0006956 | 16 | 0.094 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.094 | |
| regulation of system process | GO:0044057 | 200 | 0.092 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.091 | |
| amylopectin metabolic process | GO:2000896 | 1 | 0.091 | |
| blood circulation | GO:0008015 | 195 | 0.090 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.089 | |
| lipid localization | GO:0010876 | 126 | 0.089 | |
| estrogen secretion | GO:0035937 | 1 | 0.087 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.086 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.084 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.084 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.084 | |
| innate immune response | GO:0045087 | 157 | 0.083 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.083 | |
| regulation of protein kinase c activity | GO:1900019 | 1 | 0.082 | |
| positive regulation of estrogen secretion | GO:2000863 | 1 | 0.082 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.081 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.080 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.080 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.077 | |
| amino acid betaine metabolic process | GO:0006577 | 7 | 0.076 | |
| terpenoid metabolic process | GO:0006721 | 25 | 0.074 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.074 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.074 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.074 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.073 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.073 | |
| positive regulation of steroid hormone secretion | GO:2000833 | 2 | 0.072 | |
| arachidonic acid metabolic process | GO:0019369 | 14 | 0.072 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.071 | |
| secondary alcohol metabolic process | GO:1902652 | 3 | 0.071 | |
| porphyrin containing compound metabolic process | GO:0006778 | 22 | 0.070 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.070 | |
| liver development | GO:0001889 | 66 | 0.070 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.069 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.069 | Mouse |
| cofactor metabolic process | GO:0051186 | 80 | 0.069 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.068 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.068 | |
| circulatory system process | GO:0003013 | 197 | 0.068 | |
| renal system development | GO:0072001 | 225 | 0.067 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.065 | |
| urogenital system development | GO:0001655 | 261 | 0.065 | |
| vasoconstriction | GO:0042310 | 27 | 0.065 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.065 | |
| drug metabolic process | GO:0017144 | 4 | 0.064 | |
| toxin metabolic process | GO:0009404 | 5 | 0.064 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.062 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.062 | |
| regulation of triglyceride metabolic process | GO:0090207 | 17 | 0.062 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.062 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.062 | |
| cytokine production | GO:0001816 | 319 | 0.061 | |
| glucuronate metabolic process | GO:0019585 | 2 | 0.061 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.061 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.061 | |
| cellular response to metal ion | GO:0071248 | 31 | 0.061 | |
| tetrapyrrole metabolic process | GO:0033013 | 22 | 0.061 | |
| gland development | GO:0048732 | 330 | 0.060 | |
| regulation of fibrinolysis | GO:0051917 | 1 | 0.060 | |
| organelle assembly | GO:0070925 | 177 | 0.059 | |
| renin angiotensin regulation of aldosterone production | GO:0002018 | 3 | 0.059 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.059 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.059 | |
| opsonization | GO:0008228 | 3 | 0.059 | |
| mapk cascade | GO:0000165 | 281 | 0.059 | |
| drug catabolic process | GO:0042737 | 2 | 0.059 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.059 | |
| vitamin d3 metabolic process | GO:0070640 | 3 | 0.059 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.058 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.058 | |
| short chain fatty acid catabolic process | GO:0019626 | 2 | 0.056 | |
| maintenance of location | GO:0051235 | 89 | 0.056 | Human |
| glucose transport | GO:0015758 | 56 | 0.055 | |
| histamine uptake | GO:0051615 | 1 | 0.055 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.054 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.054 | |
| monosaccharide transport | GO:0015749 | 58 | 0.053 | |
| positive regulation of blood pressure | GO:0045777 | 21 | 0.053 | |
| muscle system process | GO:0003012 | 141 | 0.052 | |
| positive regulation of systemic arterial blood pressure | GO:0003084 | 9 | 0.052 | |
| defense response to other organism | GO:0098542 | 197 | 0.052 | |
| response to oxidative stress | GO:0006979 | 123 | 0.051 | |
| cellular response to osmotic stress | GO:0071470 | 7 | 0.051 | |
| negative regulation of phospholipase activity | GO:0010519 | 4 | 0.051 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.050 | |
| organic acid transport | GO:0015849 | 101 | 0.050 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.050 | |
| hexose metabolic process | GO:0019318 | 98 | 0.050 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.050 | |
| positive regulation of growth | GO:0045927 | 104 | 0.050 | |
| hexose transport | GO:0008645 | 56 | 0.048 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.048 | |
| xenobiotic catabolic process | GO:0042178 | 1 | 0.048 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.047 | |
| endocytosis | GO:0006897 | 168 | 0.047 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.047 | |
| regulation of lipoprotein lipase activity | GO:0051004 | 4 | 0.047 | |
| locomotory behavior | GO:0007626 | 195 | 0.047 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.047 | |
| regulation of protein activation cascade | GO:2000257 | 7 | 0.047 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.047 | Human |
| secondary metabolic process | GO:0019748 | 18 | 0.047 | |
| regulation of fatty acid biosynthetic process | GO:0042304 | 12 | 0.046 | |
| cation homeostasis | GO:0055080 | 212 | 0.046 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.046 | |
| fatty acid derivative metabolic process | GO:1901568 | 33 | 0.045 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.045 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.045 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.045 | |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.044 | |
| protein n linked glycosylation | GO:0006487 | 12 | 0.044 | |
| wound healing | GO:0042060 | 157 | 0.044 | |
| glial cell differentiation | GO:0010001 | 131 | 0.043 | |
| phasic smooth muscle contraction | GO:0014821 | 8 | 0.043 | |
| amino acid transmembrane transport | GO:0003333 | 37 | 0.043 | |
| acetylcholine catabolic process | GO:0006581 | 1 | 0.043 | |
| cellular homeostasis | GO:0019725 | 240 | 0.043 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.042 | |
| hemostasis | GO:0007599 | 78 | 0.042 | |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.042 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.042 | |
| kidney epithelium development | GO:0072073 | 121 | 0.042 | |
| cellular alcohol biosynthetic process | GO:0044108 | 3 | 0.042 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.042 | |
| response to acid chemical | GO:0001101 | 111 | 0.041 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.041 | |
| cation transport | GO:0006812 | 399 | 0.041 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.041 | |
| activation of nf kappab inducing kinase activity | GO:0007250 | 4 | 0.041 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.041 | |
| protein glycosylation | GO:0006486 | 55 | 0.040 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.040 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.040 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.040 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.039 | Human |
| regulation of defense response | GO:0031347 | 233 | 0.039 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.039 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.039 | |
| lipid homeostasis | GO:0055088 | 63 | 0.038 | |
| extracellular structure organization | GO:0043062 | 148 | 0.038 | |
| negative regulation of iron ion transport | GO:0034757 | 1 | 0.038 | |
| astrocyte activation | GO:0048143 | 2 | 0.038 | |
| response to steroid hormone | GO:0048545 | 56 | 0.037 | |
| carbohydrate transport | GO:0008643 | 62 | 0.037 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.037 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.037 | |
| glucose metabolic process | GO:0006006 | 92 | 0.037 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.037 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.037 | |
| cellular response to lipid | GO:0071396 | 145 | 0.037 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.037 | |
| urate transport | GO:0015747 | 1 | 0.037 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.036 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.035 | |
| response to stilbenoid | GO:0035634 | 22 | 0.035 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.034 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.034 | |
| positive regulation of lipid transport | GO:0032370 | 22 | 0.034 | |
| organ growth | GO:0035265 | 117 | 0.033 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.033 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.033 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.033 | |
| female gamete generation | GO:0007292 | 74 | 0.033 | Mouse |
| lipid transport | GO:0006869 | 98 | 0.033 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.033 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.032 | |
| camera type eye development | GO:0043010 | 266 | 0.032 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.032 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.032 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.032 | |
| gliogenesis | GO:0042063 | 141 | 0.032 | |
| immune effector process | GO:0002252 | 321 | 0.032 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.032 | |
| negative regulation of lipoprotein lipase activity | GO:0051005 | 1 | 0.032 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.032 | |
| response to estrogen | GO:0043627 | 24 | 0.032 | |
| multicellular organism growth | GO:0035264 | 161 | 0.032 | |
| response to drug | GO:0042493 | 75 | 0.031 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.031 | |
| muscle contraction | GO:0006936 | 101 | 0.031 | |
| blood coagulation | GO:0007596 | 76 | 0.031 | |
| positive regulation of protein activation cascade | GO:2000259 | 2 | 0.031 | |
| regulation of renin secretion into blood stream | GO:1900133 | 4 | 0.031 | |
| glucocorticoid metabolic process | GO:0008211 | 9 | 0.030 | |
| regulation of protein localization | GO:0032880 | 231 | 0.030 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.030 | |
| carbohydrate transmembrane transport | GO:0034219 | 10 | 0.030 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.030 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.030 | |
| immune response in mucosal associated lymphoid tissue | GO:0002386 | 2 | 0.030 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.030 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.029 | |
| heme metabolic process | GO:0042168 | 16 | 0.029 | |
| response to alcohol | GO:0097305 | 48 | 0.029 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.029 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.029 | |
| renal system process involved in regulation of systemic arterial blood pressure | GO:0003071 | 15 | 0.029 | |
| regulation of coagulation | GO:0050818 | 31 | 0.029 | |
| coagulation | GO:0050817 | 78 | 0.029 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.028 | |
| regulation of acute inflammatory response | GO:0002673 | 27 | 0.028 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.028 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.028 | |
| cellular biogenic amine metabolic process | GO:0006576 | 28 | 0.028 | |
| sensory perception of pain | GO:0019233 | 47 | 0.028 | |
| l ascorbic acid metabolic process | GO:0019852 | 4 | 0.028 | |
| carnitine transport | GO:0015879 | 3 | 0.027 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.027 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.027 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.027 | |
| negative regulation of protein activation cascade | GO:2000258 | 3 | 0.027 | |
| response to monosaccharide | GO:0034284 | 67 | 0.027 | |
| kidney development | GO:0001822 | 213 | 0.027 | |
| protein activation cascade | GO:0072376 | 19 | 0.027 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.027 | |
| l ascorbic acid biosynthetic process | GO:0019853 | 3 | 0.026 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.026 | |
| regulation of fatty acid oxidation | GO:0046320 | 10 | 0.026 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.026 | |
| regulation of tube size | GO:0035150 | 57 | 0.026 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.026 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.026 | |
| positive regulation of coagulation | GO:0050820 | 13 | 0.026 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.026 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.026 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.025 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.025 | |
| cofactor transport | GO:0051181 | 4 | 0.025 | |
| glycosylation | GO:0070085 | 62 | 0.025 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.025 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.025 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.025 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.025 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.025 | |
| oligopeptide transmembrane transport | GO:0035672 | 4 | 0.024 | |
| regulation of phagocytosis | GO:0050764 | 33 | 0.024 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.024 | |
| regulation of ion transport | GO:0043269 | 215 | 0.024 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.024 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.024 | |
| dibenzo p dioxin metabolic process | GO:0018894 | 1 | 0.024 | |
| organ regeneration | GO:0031100 | 2 | 0.024 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.024 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.024 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.023 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.023 | |
| cell growth | GO:0016049 | 130 | 0.023 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.023 | |
| axonogenesis | GO:0007409 | 274 | 0.023 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.023 | |
| endocrine process | GO:0050886 | 39 | 0.023 | |
| chemotaxis | GO:0006935 | 247 | 0.023 | |
| hormone secretion | GO:0046879 | 128 | 0.023 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.023 | |
| regulation of phosphatidylinositol 3 kinase signaling | GO:0014066 | 30 | 0.023 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.023 | |
| alpha amino acid biosynthetic process | GO:1901607 | 15 | 0.023 | |
| cellular amino acid catabolic process | GO:0009063 | 25 | 0.022 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.022 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.022 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.022 | Human |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.022 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.022 | |
| regulation of protein transport | GO:0051223 | 163 | 0.022 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.022 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.022 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.022 | |
| calcium ion transport | GO:0006816 | 159 | 0.022 | |
| regulation of complement activation | GO:0030449 | 7 | 0.021 | |
| sterol esterification | GO:0034434 | 3 | 0.021 | |
| mitochondrion organization | GO:0007005 | 134 | 0.021 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.021 | |
| activation of immune response | GO:0002253 | 138 | 0.020 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.020 | |
| uronic acid metabolic process | GO:0006063 | 2 | 0.020 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.020 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.020 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.020 | |
| response to testosterone | GO:0033574 | 3 | 0.020 | |
| positive regulation of peptidyl serine phosphorylation | GO:0033138 | 25 | 0.020 | |
| renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure | GO:0001999 | 6 | 0.020 | |
| cellular response to estrogen stimulus | GO:0071391 | 12 | 0.020 | |
| myosin filament assembly | GO:0031034 | 2 | 0.020 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.020 | |
| intestinal absorption | GO:0050892 | 13 | 0.020 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.020 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.020 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.020 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.020 | |
| inter male aggressive behavior | GO:0002121 | 3 | 0.020 | |
| hepatocyte growth factor receptor signaling pathway | GO:0048012 | 3 | 0.020 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.019 | |
| tryptophan metabolic process | GO:0006568 | 4 | 0.019 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.019 | |
| acute inflammatory response | GO:0002526 | 41 | 0.019 | |
| retinal blood vessel morphogenesis | GO:0061304 | 3 | 0.019 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.019 | |
| regulation of organ growth | GO:0046620 | 61 | 0.019 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.019 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.019 | |
| negative regulation of coagulation | GO:0050819 | 11 | 0.018 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.018 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.018 | |
| folic acid containing compound metabolic process | GO:0006760 | 3 | 0.018 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.018 | |
| pigment metabolic process | GO:0042440 | 32 | 0.018 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.018 | |
| negative regulation of gluconeogenesis | GO:0045721 | 9 | 0.018 | |
| directional locomotion | GO:0033058 | 3 | 0.018 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.018 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.018 | |
| protein secretion | GO:0009306 | 111 | 0.018 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.018 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.018 | |
| regulation of intestinal cholesterol absorption | GO:0030300 | 4 | 0.018 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.018 | |
| gonad development | GO:0008406 | 141 | 0.018 | Mouse |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.018 | |
| c21 steroid hormone metabolic process | GO:0008207 | 7 | 0.018 | Mouse |
| collagen fibril organization | GO:0030199 | 32 | 0.017 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.017 | |
| forebrain development | GO:0030900 | 302 | 0.017 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.017 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.017 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.017 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.017 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.017 | |
| cell maturation | GO:0048469 | 127 | 0.017 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.017 | |
| peptide transport | GO:0015833 | 133 | 0.017 | |
| neuron death | GO:0070997 | 154 | 0.017 | |
| nephron development | GO:0072006 | 109 | 0.017 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.017 | |
| developmental maturation | GO:0021700 | 193 | 0.017 | |
| one carbon metabolic process | GO:0006730 | 1 | 0.017 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.016 | |
| regulation of wound healing | GO:0061041 | 40 | 0.016 | |
| regulation of toll signaling pathway | GO:0008592 | 1 | 0.016 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.016 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.016 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.016 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.016 | |
| water soluble vitamin biosynthetic process | GO:0042364 | 3 | 0.016 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.016 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.016 | |
| bone development | GO:0060348 | 120 | 0.016 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.016 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.016 | Mouse |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.016 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.016 | |
| sulfate assimilation | GO:0000103 | 3 | 0.016 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.016 | |
| regulation of gluconeogenesis | GO:0006111 | 30 | 0.016 | |
| long chain fatty acid metabolic process | GO:0001676 | 26 | 0.015 | |
| regulation of protein stability | GO:0031647 | 52 | 0.015 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.015 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.015 | |
| histamine transport | GO:0051608 | 2 | 0.015 | |
| response to hypoxia | GO:0001666 | 58 | 0.015 | |
| positive regulation of phagocytosis | GO:0050766 | 26 | 0.015 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.015 | |
| response to oxygen levels | GO:0070482 | 62 | 0.015 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.015 | |
| regulation of cell motility | GO:2000145 | 236 | 0.015 | |
